Citigroup Inc Cin Cor Pharma, Inc. Transaction History

Citigroup Inc

  • $169 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023
SELL
$10.75 - $29.84 $15,146 - $42,044
-1,409 Reduced 55.15%
1,146 $14,000
Q3 2022

Nov 10, 2022
BUY
$19.9 - $38.94 $25,392 - $49,687
1,276 Added 99.77%
2,555 $84,000
Q2 2022

Aug 10, 2022
BUY
$13.67 - $25.74 $3,540 - $6,666
259 Added 25.39%
1,279 $24,000
Q1 2022

May 12, 2022
BUY
$14.13 - $28.49 $14,412 - $29,059
1,020 New
1,020 $18,000

Others Institutions Holding CINC

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CinCor Pharma, Inc.

CINC Quotes by TradingView
  • Ticker CINC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,764,300
  • Description
  • CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial...
More about CINC
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email